Literature DB >> 15808598

The ratio between class II and class I collagenase determines the amount of neutral protease activity required for efficient islet release from the rat pancreas.

H Brandhorst1, A Alt, S Huettler, N Raemsch-Guenther, M Kurfuerst, R G Bretzel, D Brandhorst.   

Abstract

UNLABELLED: Previous investigations clearly showed that the successful release of islets from the pancreas is mediated by both neutral protease (NP) and collagenase, consisting of subclasses I and II showing different capacities to cleave islets from the pancreas. Since no informations about the optimal ratio between class II and class I collagenase (II/I-ratio) are available yet, the present study sought to evaluate the efficient range for the II/I-ratio.
METHODS: Following intraductal pancreas collagenase distension, rat islets were isolated utilizing 20 PZ-U Serva collagenase NB 1 and 1.0 or 0.4 DMC-U NP. After purification we determined the islet yield (IEQ), viability (trypan-blue exclusion) and function in diabetic nude mice.
RESULTS: At 1.0 DMC-U NP, a II/I-ratio of 2.6, 1.5 or 0.7 yielded 2200 +/- 280, 2185 +/- 420, and 2205 +/-90 IEQ, respectively (ns). Viability varied between 70% and 80% (ns). Digestion time was significantly lowest (P < .05) using a II/I-ratio of 0.7. Utilization of 0.4 DMC-U NP resulted in a viability of >98% among all experimental groups (P < .001 vs 1.0 DMC-U). Islet yield decreased at a II/I-ratio of 2.6 (1520 +/- 120 IEQ, P < .05) and 1.5 (1780 +/- 130 IEQ, ns), but not at 0.7 (2310 +/- 160 IEQ, ns). Again, digestion time was lowest (P < .001) using a II/I- ratio of 0.7. Transplantation into diabetic nude mice demonstrated islet function in all experimental groups.
CONCLUSIONS: NP significantly affects islet viability. This study indicates that the minimal amount of NP required for efficient islet cleavage depends on the II/I-ratio.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808598     DOI: 10.1016/j.transproceed.2004.12.256

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

Review 1.  Enzyme Development for Human Islet Isolation: Five Decades of Progress or Stagnation?

Authors:  Daniel Brandhorst; Heide Brandhorst; Paul R V Johnson
Journal:  Rev Diabet Stud       Date:  2017-06-12

2.  Comparison of Clostripain and Neutral Protease as Supplementary Enzymes for Human Islet Isolation.

Authors:  Heide Brandhorst; Paul R Johnson; Johanna Mönch; Manfred Kurfürst; Olle Korsgren; Daniel Brandhorst
Journal:  Cell Transplant       Date:  2018-11-13       Impact factor: 4.064

3.  Comparison of Neutral Proteases and Collagenase Class I as Essential Enzymes for Human Islet Isolation.

Authors:  Heide Brandhorst; Manfred Kurfürst; Paul R Johnson; Olle Korsgren; Daniel Brandhorst
Journal:  Transplant Direct       Date:  2015-12-15

4.  Quantifying the Effects of Different Neutral Proteases on Human Islet Integrity.

Authors:  Heide Brandhorst; Paul R V Johnson; Olle Korsgren; Daniel Brandhorst
Journal:  Cell Transplant       Date:  2017-11       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.